ScholarIQanswers from OpenAlex & ORCID
Jonathan Goldin
ResearcherPublications, citations & collaboration network
Jonathan Goldin is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Jonathan Goldin have?
ScholarIQindexed works
Jonathan Goldin has 458 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jonathan Goldin have?
ScholarIQcitation count
Jonathan Goldin has 27,931 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Jonathan Goldin?
ScholarIQh-index
Jonathan Goldin has an h-index of 76 in OpenAlex.
What is the i10-index of Jonathan Goldin?
ScholarIQi10-index
Jonathan Goldin has an i10-index of 202 in OpenAlex.
What is the ORCID of Jonathan Goldin?
ScholarIQorcid
The ORCID for Jonathan Goldin is on the source record.
What is the OpenAlex record for Jonathan Goldin?
ScholarIQopenalex
The OpenAlex for Jonathan Goldin is on the source record.
What are the most-cited papers on Jonathan Goldin?
ScholarIQmost cited works
Assessment of Coronary Artery Disease by Cardiac Computed Tomography
Matthew J. Budoff, Stephan Achenbach, Roger S. Blumenthal, J. Jeffrey Carr, Jonathan Goldin, Philip Greenland, Alan D. Guerci, João A.C. Lima, Daniel J. Rader, Geoffrey D. Rubin, Leslee J. Shaw, Susan E. Wiegers
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
Keith Sullivan, Ellen Goldmuntz, Lynette Keyes-Elstein, Peter A. McSweeney, Ashley Pinckney, Beverly Welch, Maureen D. Mayes, Richard A. Nash, Leslie J. Crofford, Barry Eggleston, Sharon Castina, Linda M. Griffith, Julia Goldstein, Dennis Wallace, Oana Craciunescu, Dinesh Khanna, Rodney J. Folz, Jonathan Goldin, E. William St. Clair, James R. Seibold, Kristine Phillips, Shin Mineishi, Robert W. Simms, Karen K. Ballen, Mark H. Wener, George E. Georges, Shelly Heimfeld, Chitra Hosing, Stephen J. Forman, Suzanne Kafaja, Richard M. Silver, Leroy Griffing, Jan Storek, Sharon LeClercq, Richard Brasington, Mary Ellen Csuka, Christopher Bredeson, Carolyn A. Keever-Taylor, Robyn T. Domsic, M. Bashar Kahaleh, Thomas A. Medsger, Daniel E. Furst
Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease
Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements, Michael D. Roth, Daniel E. Furst, Richard M. Silver, Jonathan Goldin, Edgar Arriola, Charlie Strange, Marcy B. Bolster, James R. Seibold, D. Riley, Vivien Hsu, John Varga, Dean E. Schraufnagel, Arthur C. Theodore, Robert W. Simms, Robert A. Wise, Fred Wigley, Barbara White, Virginia Steen, Charles A. Read, Maureen D. Mayes, Ed Parsley, Kamal K. Mubarak, M. Kari Connolly, Jeffrey A. Golden, Mitchell A. Olman, Barri J. Fessler, Naomi F. Rothfield, Mark L. Metersky, Dinesh Khanna, Ning Li, Gang Li
Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment
Whitney B. Pope, Grace Hyun J. Kim, Jing Huo, Jeffry R. Alger, Matthew S. Brown, David Gjertson, Victor Sai, Jonathan R. Young, Leena Tekchandani, Timothy F. Cloughesy, Paul S. Mischel, Albert Lai, Phioanh L. Nghiemphu, Syed Rahmanuddin, Jonathan Goldin